State Street Corp Abbott Laboratories Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Abbott Laboratories stock. As of the latest transaction made, State Street Corp holds 76,720,429 shares of ABT stock, worth $8.76 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares

76,720,429

Previous 74,396,622 3.12%

Holding current value

$8.76 Billion

Previous $7.73 Billion 13.15%

% of portfolio

0.36%

Previous 0.34%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $233 Million - $275 Million	2,323,807 Added 3.12%	76,720,429 $8.75 Billion
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $34.5 Million - $38.5 Million	-342,018 Reduced 0.46%	74,396,622 $7.73 Billion
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $5.64 Million - $6.23 Million	51,464 Added 0.07%	74,738,640 $8.49 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $131 Million - $161 Million	1,453,969 Added 1.99%	74,687,176 $8.22 Billion
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $151 Million - $182 Million	-1,583,902 Reduced 2.12%	73,233,207 $7.09 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $137 Million - $153 Million	1,362,889 Added 1.86%	74,817,109 $8.16 Billion
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $112 Million - $132 Million	-1,157,666 Reduced 1.55%	73,454,220 $7.44 Billion
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $45 Million - $52.8 Million	473,024 Added 0.64%	74,611,886 $8.19 Billion
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $34 Million - $39.3 Million	351,136 Added 0.48%	74,138,862 $7.17 Billion
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $7.52 Million - $9.08 Million	73,640 Added 0.1%	73,787,726 $8.02 Billion
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $69.3 Million - $84.5 Million	-607,965 Reduced 0.82%	73,714,086 $8.72 Billion
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $219 Million - $268 Million	1,896,462 Added 2.62%	74,322,051 $10.5 Billion
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $79.4 Million - $87.8 Million	680,543 Added 0.95%	72,425,589 $8.56 Billion
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $129 Million - $152 Million	1,222,298 Added 1.73%	71,745,046 $8.32 Billion
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $88 Million - $104 Million	-808,415 Reduced 1.13%	70,522,748 $8.45 Billion
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $246 Million - $268 Million	-2,343,608 Reduced 3.18%	71,331,163 $7.81 Billion
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $80.8 Million - $98.1 Million	-881,250 Reduced 1.18%	73,674,771 $8.02 Billion
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $36.1 Million - $46.2 Million	471,500 Added 0.64%	74,556,021 $6.82 Billion
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $4.65 Billion - $6.81 Billion	74,084,521 New	74,084,521 $5.85 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Abbott Laboratories Transaction History